You are here: Industry Insights > BNT162

News List

BioNTech and Fosun to supply 100 million Covid-19 vaccine doses to China pharmaceutical-technology
December 18, 2020
German company BioNTech and Shanghai Fosun Pharmaceutical (Fosun Pharma) have entered into an agreement to supply initially 100 million doses of mRNA-based Covid-19 vaccine candidate, BNT162, to Mainland China next year.
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU contractpharma
September 24, 2020
Could supply the EU with 200 million doses of mRNA-based vaccine candidate against SARS-CoV-2.
BioNTech to Receive Funding to Support COVID-19 Vaccine Program americanpharmaceuticalreview
September 22, 2020
BioNTech announced it will receive a grant of up to 375 million Euro from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.
BioNTech to acquire Novartis site for Covid-19 vaccine production pharmaceutical-technology
September 21, 2020
BioNTech has signed a share purchase agreement with Novartis to acquire a manufacturing site to boost its messenger RNA (mRNA)-based BNT162 Covid-19 vaccine candidate production capacity.
BioNTech to Receive German Federal Ministry Funding for COVID-19 Vax contractpharma
September 16, 2020
BioNTech SE will receive a grant of up to $445.4 million) from an initiative by the German Federal Ministry of Education and Research (BMBF) to support the accelerated development of SARS-CoV-2 vaccines.
Pfizer, BioNTech Reach Deal with Japanese Government contractpharma
August 04, 2020
Supply of 120 million vaccine doses to be provided in the first half of 2021, subject to regulatory approval.
Pfizer and BioNTech sign deal with Japan for 120 mn doses of mRNA-based COVID-19 vaccine expresspharma
August 03, 2020
The companies have begun a Phase 2b/3 safety and efficacy trial and remain on track to seek regulatory review as early as October 2020.
U.S. Inks $2B COVID-19 Vax Deal with Pfizer, BioNTech contractpharma
July 24, 2020
U.S. government placed an initial order of 100 million doses and can acquire up to 500 million additional doses.
US inks $1.95bn deal for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 23, 2020
The US Department of Health and Human Services (HHS) and the Department of Defense have executed an agreement valued at $1.95bn with Pfizer and BioNTech for up to 600 million doses of the companies’ Covid-19 vaccine candidate, BNT162.
UK enters supply agreement for Pfizer and BioNTech’s Covid-19 vaccine pharmaceutical-technology
July 21, 2020
The UK Government has signed an agreement with Pfizer and BioNTech for the supply of 30 million doses of the companies’ mRNA-based Covid-19 vaccine candidate, BNT162.

Previous page 1 2 Next page